Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

RANGE: docetaxel with or without ramucirumab for metastatic urothelial carcinoma

Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA
RANGE: docetaxel with or without ramucirumab for metastatic urothelial carcinoma ( Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA )
10 Sep 2017

Long term efficacy of denosumab for giant cell bone tumours

Prof Emanuela Palmerini - Rizzoli Orthopedic Institute, Bologna, Italy
Long term efficacy of denosumab for giant cell bone tumours ( Prof Emanuela Palmerini - Rizzoli Orthopedic Institute, Bologna, Italy )
9 Sep 2017

Returning to work after cancer

Dr Cecilie Kiserud - Oslo University Hospital, Oslo, Norway
Returning to work after cancer ( Dr Cecilie Kiserud - Oslo University Hospital, Oslo, Norway )
9 Sep 2017

STORM trial to identify genetic variability in metastatic breast cancer

Dr David Cox - Cancer Research Center of Lyon, Lyon, France
STORM trial to identify genetic variability in metastatic breast cancer ( Dr David Cox - Cancer Research Center of Lyon, Lyon, France )
9 Sep 2017

The UNICANCER-NeoPAL study of letrozole and palbociclib in luminal cancer

Dr Paul Cottu - Institut Curie, Paris, France
The UNICANCER-NeoPAL study of letrozole and palbociclib in luminal cancer ( Dr Paul Cottu - Institut Curie, Paris, France )
9 Sep 2017

STAMPEDE: Abiraterone acetate plus prednisolone or docetaxel

Matthew Sydes - Medical Research Council, London, UK
STAMPEDE: Abiraterone acetate plus prednisolone or docetaxel ( Matthew Sydes - Medical Research Council, London, UK )
9 Sep 2017

Problems with care: a patients perspective

Ana Kogan Wais - Ewing sarcoma patient, Madrid, Spain
Problems with care: a patients perspective ( Ana Kogan Wais - Ewing sarcoma patient, Madrid, Spain )
9 Sep 2017

Reduced work ability in cancer survivors

Dr Cecilie Kiserud - Oslo University Hospital, Oslo, Norway
Reduced work ability in cancer survivors ( Dr Cecilie Kiserud - Oslo University Hospital, Oslo, Norway )
9 Sep 2017

Problems with survivorship care in Europe

Prof Francesco De Lorenzo - University of Naples Federico II, Naples, Italy
Problems with survivorship care in Europe ( Prof Francesco De Lorenzo - University of Naples Federico II, Naples, Italy )
9 Sep 2017

Underprovision and inequality of specialised cancer care

Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Greece
Underprovision and inequality of specialised cancer care ( Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Greece )
9 Sep 2017

Regorafenib versus lomustine for relapsed glioblastoma

Dr Giuseppe Lombardi - Istituto Oncologico Veneto, Padova, Italy
Regorafenib versus lomustine for relapsed glioblastoma ( Dr Giuseppe Lombardi - Istituto Oncologico Veneto, Padova, Italy )
9 Sep 2017

Reviewing LORELEI, mindACT and ExteNET trials in breast cancer

Prof Miguel Martin - Hospital General Universitario Gregorio Marañón, Madrid, Spain
Reviewing LORELEI, mindACT and ExteNET trials in breast cancer ( Prof Miguel Martin - Hospital General Universitario Gregorio Marañón, Madrid, Spain )
9 Sep 2017